MoneyWorks4Me

Cipla informs about press release

30 Oct 2015 Evaluate

Cipla has informed about a press release dated October 29, 2015, titled ‘Cipla Strengthens its Focus on Biotech’.

The above information is a part of company’s filings submitted to BSE.

Cipla Share Price

1419.25 -12.60 (-0.88%)
19-Aug-2026 14:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1896.70
Dr. Reddys Labs. 1171.85
Cipla 1419.25
Lupin 2219.50
Zydus Lifesciences 1109.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: